Although growth stock picks can be highly volatile, they can make good long-term investments. They may be well-known stars or quiet gems, but they do share one common attribute—they are growing at a higher-than-average rate within their industry, or within the market as a whole, and could keep growing for years or decades.
And keep in mind that we focus on growth stocks, which have a good long-term history and favourable prospects. We downplay momentum stocks that tend to attract many investors simply because they are moving faster than the market averages, but are liable to fall sharply when their momentum fades.
There’s room for growth stock investing in your portfolio, but make sure you follow our TSI Network three-part Successful Investor strategy for your overall portfolio:
- Invest mainly in well-established companies;
- Spread your money out across most if not all of the five main economic sectors (Manufacturing & Industry; Resources & Commodities; Consumer; Finance; Utilities);
- Downplay or avoid stocks in the broker/media limelight.
Make better stock picks when you read this FREE Special Report, Canadian Growth Stocks: WestJet Stock, RioCan Stock and More.
In the three months ended June 30, 2012, Pason’s revenue rose 29.8%, to $81.1 million from $62.4 million a year earlier. Cash flow rose 31.5%, to $30.1 million, or $0.37 a share, from $22.9 million, or $0.28.
Even with declining oil prices and continued low gas prices, drilling activity rose 6% in Canada and the U.S. in the latest quarter, with a combined 188,291 active days and a rig count of 2,069, compared to 177,791 days and 1,954 rigs a year earlier.
...
In the three months ended June 29, 2012, Symantec’s earnings per share excluding one-time items rose 7.5%, to $0.43 from $0.40. That beat the consensus estimate of $0.33.
Revenue rose just 0.9%, to $1.67 billion from $1.65 billion. Stronger sales of security software to businesses offset lower sales to consumers, who account for about 30% of Symantec’s overall revenue. As well, higher sales in the Americas and Asia helped overcome declines in Europe.
...
In mid-February 2012, ACI completed its purchase of S1 Corp. for $540 million in cash and stock. This acquisition is a good fit: S1 sells transaction software for banks, credit unions, retailers and other payment processors. It has over 3,000 clients worldwide.
In the second quarter of 2012, ACI’s revenue rose 32.1%, to $149.8 million from $113.4 million a year earlier. S1′s $43.1-million contribution was the main reason for the gain.
...
The government of Madagascar has just signed an operating permit that will let Sherritt and its partners begin production at Ambatovy, which will be one of the world’s biggest nickel mines.
The $5.5-billion project will be able to produce 60,000 tonnes of refined nickel a year for the next three decades.
...
The company serves 81 destinations in North America, Central America and the Caribbean. Its fleet of 99 modern Boeing 737s are 30% more fuel efficient than older aircraft. WestJet is scheduled to receive 36 more 737s through 2018.
In the three months ended June 30, 2012, WestJet’s revenue rose 9.0%, to $809.3 million from $742.3 million a year earlier. Demand for its flights remains high, and it has entered into new partnerships with other airlines; these were the main reasons for the higher revenue.
...
The remaining 30% of its revenue comes from its Securities Processing Solutions division, which provides transaction-processing services that automate many functions, including taking and executing orders, confirming trades, settlement and accounting.
Big changes since spinoff
...
Earnings jumped 29.6% in the three months ended June 30, 2012, to $0.70 a share from $0.54 a year earlier. Revenue rose 8.3%, to $2.1 billion from $2.0 billion. Sales to government customers rose 13.6%. However, weak economic conditions in Europe cut sales to businesses by 1.6%.
It also raised its quarterly dividend by 18.2%, to $0.26 a share from $0.22. The new annual rate of $1.04 yields 2.2%.
...
Pfizer should complete the offering in the first half of 2013. After that, it will probably hand out its remaining shares in Zoetis to its own shareholders.
Pfizer is a buy.
...